The Chronic Disease Flexible Coverage Act (H.R. 3800), was introduced in the U.S. House of Representatives and approved by the U.S. House Ways and Means Committee by a vote of 34-6.
Thursday, March 30: Judge Reed C. O’Connor, of the U.S. District Court for the Northern District of Texas, granted Braidwood Management Inc.'s request to block Section 2713 of the Public Health Service Act as amended by the ACA, that requires coverage without cost-sharing of preventive services to which the U.S. Preventive Services Task Force (USPTF) assigns a rating of “A” or “B”.
On March 6, 2023, Senators John Thune (R-SD) and Tom Carper (D-DE), introduced the Chronic Disease Management Act of 2021 (CDMA) in the United States Senate.
According to EBRI survey findings, 80% of employers won’t impose cost sharing on preventive services if the ACA preventive services mandate is overturned. The Section 2713 mandate incorporates V-BID principles to expand first-dollar coverage of preventive care services for an estimated 167 million Americans.
This week’s episode of Tradeoffs, a national podcast addressing America's toughest health policy challenges, focuses on the problem of lack of coverage for follow up testing after positive initial cancer screening.
The Inflation Reduction Act of 2022, which passed the Senate on August 7th, includes several V-BID related items
In a July 7 press release, CMS Proposes Physician Payment Rule to Expand Access to High-Quality Care”, CMS proposed that a follow-up colonoscopy to an at-home test be considered a preventive service, which means that cost sharing would be waived for people with Medicare.
This week, national media stories and a new JAMA Network Open publication bring attention to the problem of cost-related barriers for follow-up evaluations for post-initial cancer screening, as well as the clinical and economic benefits of policies that remove these impediments.
The Biden Administration has released Frequently Asked Questions Part 51 regarding implementation of the ACA, FFCRA, Coronavirus Aid Relief, and CARES Act. The guidance reaffirmed no out-of-pocket costs for COVID testing as well as the elimination of cost-sharing for colonoscopies following a positive non-invasive colorectal cancer screening test.
October 20, 2021– the Centers for Medicare and Medicaid Services Innovation Center (CMMI) has released a white paper detailing its strategic direction for the next decade.
New NPC-funded research by the Employee Benefit Research Institute (EBRI) has found that many employers would like to further broaden pre-deductible coverage for medications and health services used to treat common chronic conditions.
In July 2021, the DC Health Benefit Exchange Authority (DCHBX) voted to adopt key recommendations from its Social Justice and Health Disparities Working Group which aim to expand access to providers and health systems, eliminate health outcome disparities, and ensure equitable treatment in health care settings and delivery of health care services for communities of color.
On April 28, 2021, Senators John Thune (R-SD) and Tom Carper (D-DE), re-introduced the Chronic Disease Management Act in the United States Senate. This bill builds upon its previous versions and includes criteria from the 2019 IRS guidance to further increase the flexibility of HSA-HDHPs to cover chronic disease services on pre-deductible basis.
On Tuesday, April 20, 2021, V-BID Center director, A. Mark Fendrick, presented at the Federal Employees Health Benefits Program Carrier Conference, co-hosted by the U.S. Office of Personnel Management (OPM) and America’s Health Insurance Plans (AHIP).
The 2020 Kaiser Family Foundation Survey of Employer Health Benefits reported significant uptake of a 2019 federal rule that expanded the number of clinical services that may be covered before enrollees meet their plan deductibles.
